Publications by authors named "Seichiro Kanaya"
Article Synopsis
- Nivolumab is the standard treatment in Japan for patients with advanced esophageal squamous cell carcinoma (ESCC) who can't tolerate traditional chemotherapy.
- A study analyzed clinical data of 93 patients treated with nivolumab to assess inflammatory prognostic factors like CAR (C-reactive protein/albumin ratio) and their impact on survival.
- Results showed that patients with a CAR value below 0.62 had significantly longer overall survival, indicating that CAR is a useful predictor of prognosis in these patients.